share_log

Institutional Investors Must Be Pleased After a 5.0% Gain Last Week That Adds to Hims & Hers Health, Inc.'s (NYSE:HIMS) One-year Returns

Institutional Investors Must Be Pleased After a 5.0% Gain Last Week That Adds to Hims & Hers Health, Inc.'s (NYSE:HIMS) One-year Returns

在上週上漲5.0%之後,機構投資者一定會感到高興,這增加了Hims & Hers, Inc.的健康。”s(紐約證券交易所代碼:HIMS)一年期回報率
Simply Wall St ·  04/28 09:47

Key Insights

關鍵見解

  • Institutions' substantial holdings in Hims & Hers Health implies that they have significant influence over the company's share price
  • A total of 15 investors have a majority stake in the company with 51% ownership
  • Insiders have been selling lately
  • 各機構持有Hims & Hers Health的大量股權意味着它們對公司的股價有重大影響
  • 共有15名投資者持有該公司的多數股權,所有權爲51%
  • 業內人士最近一直在拋售

To get a sense of who is truly in control of Hims & Hers Health, Inc. (NYSE:HIMS), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are institutions with 55% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

要了解誰真正控制了Hims & Hers Health, Inc.(紐約證券交易所代碼:HIMS),了解業務的所有權結構非常重要。而持有最大份額的集團是擁有55%所有權的機構。換句話說,該集團面臨最大的上行潛力(或下行風險)。

And as as result, institutional investors reaped the most rewards after the company's stock price gained 5.0% last week. The one-year return on investment is currently 7.9% and last week's gain would have been more than welcomed.

結果,在上週公司股價上漲5.0%之後,機構投資者獲得了最大的回報。目前,一年的投資回報率爲7.9%,上週的漲幅本來會非常受歡迎。

Let's take a closer look to see what the different types of shareholders can tell us about Hims & Hers Health.

讓我們仔細看看不同類型的股東能告訴我們關於Hims & Hers Hers Health的哪些信息。

ownership-breakdown
NYSE:HIMS Ownership Breakdown April 28th 2024
紐約證券交易所:HIMS 所有權明細 2024 年 4 月 28 日

What Does The Institutional Ownership Tell Us About Hims & Hers Health?

關於他和她的健康狀況,機構所有權告訴我們什麼?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構根據近似於當地市場的指數來衡量自己的表現。因此,他們通常會更多地關注主要指數中包含的公司。

Hims & Hers Health already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Hims & Hers Health, (below). Of course, keep in mind that there are other factors to consider, too.

Hims & Hers Health已經在股票登記處設立了機構。事實上,他們擁有該公司可觀的股份。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得查看Hims & Hers Health過去的收益軌跡(見下文)。當然,請記住,還有其他因素需要考慮。

earnings-and-revenue-growth
NYSE:HIMS Earnings and Revenue Growth April 28th 2024
紐約證券交易所:HIMS收益和收入增長 2024年4月28日

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Hims & Hers Health is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is the CEO Andrew Dudum with 9.2% of shares outstanding. For context, the second largest shareholder holds about 6.6% of the shares outstanding, followed by an ownership of 5.8% by the third-largest shareholder.

由於機構投資者擁有已發行股票的一半以上,董事會可能必須注意他們的偏好。Hims & Hers Hers Health 不歸對沖基金所有。從我們的數據來看,我們可以看到最大股東是首席執行官安德魯·杜杜姆,其已發行股份佔9.2%。就背景而言,第二大股東持有約6.6%的已發行股份,其次是第三大股東持有5.8%的所有權。

A closer look at our ownership figures suggests that the top 15 shareholders have a combined ownership of 51% implying that no single shareholder has a majority.

仔細觀察我們的所有權數據就會發現,前15名股東的合併所有權爲51%,這意味着沒有一個股東擁有多數股東。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

雖然研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議以更深入地了解股票的預期表現也是一種好做法。有很多分析師在報道該股,因此可能也值得一看他們的預測。

Insider Ownership Of Hims & Hers Health

Hims & Hers Hers Health 的內部所有權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

不同國家對內部人士的定義可能略有不同,但董事會成員總是計算在內。公司管理層對董事會的回答,董事會應代表股東的利益。值得注意的是,有時高層管理人員自己也在董事會中。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部所有權是一件好事。但是,在某些情況下,這使其他股東更難追究董事會對決策的責任。

Our information suggests that insiders maintain a significant holding in Hims & Hers Health, Inc.. Insiders own US$367m worth of shares in the US$2.7b company. That's quite meaningful. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.

我們的信息表明,內部人士持有Hims & Hers Health, Inc.的大量股份。內部人士擁有這家27億美元的公司價值3.67億美元的股份。這很有意義。大多數人會很高興看到董事會與他們一起投資。您不妨訪問這張顯示內部人士近期交易的免費圖表。

General Public Ownership

一般公有制

With a 25% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Hims & Hers Health. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

擁有25%所有權的公衆,主要由個人投資者組成,對Hims & Hers Hers Health有一定程度的影響力。儘管這種所有權規模可能不足以影響對他們有利的政策決定,但它們仍然可以對公司政策產生集體影響。

Private Equity Ownership

私募股權所有權

Private equity firms hold a 5.8% stake in Hims & Hers Health. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

私募股權公司持有Hims & Hers Health5.8%的股份。這表明他們可以在關鍵政策決策中發揮影響力。一些投資者可能會爲此感到鼓舞,因爲私募股權有時能夠鼓勵制定有助於市場看到公司價值的策略。或者,這些持有人可能會在投資上市後退出投資。

Next Steps:

後續步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 3 warning signs for Hims & Hers Health you should be aware of.

我覺得看看究竟誰擁有一家公司非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。一個很好的例子:我們發現了 3 個你應該注意的 Hims & Hers Hers Health 警告信號。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果你像我一樣,你可能需要考慮這家公司是會成長還是會萎縮。幸運的是,您可以查看這份免費報告,其中顯示了分析師對其未來的預測。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論